Updates - GlaxoSmithKline Pharmaceuticals LimitedNSE · annual report · 2 pages
VerifiedArchived copy Company dossier
GlaxoSmithKline Pharmaceuticals
NSE:GLAXO · ISIN INE159A01016
- Close
- ₹2,626.4 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
GlaxoSmithKline Pharmaceuticals
Business
Business evidence pack
Source documentsPrimary material for understanding GlaxoSmithKline Pharmaceuticals
Business-model synthesis will be generated from the company's annual reports, investor presentations and conference-call material. Until that layer is reconciled, IndiaTicker shows the source pack instead of company-specific claims.
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Letter For Website Link For Annual ReportBSE · annual report · 2 pages
VerifiedArchived copy GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Reg. 34 (1) Annual Report.BSE · annual report · 241 pages
VerifiedArchived copy